343 related articles for article (PubMed ID: 3091132)
1. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
Rényi L
Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
[TBL] [Abstract][Full Text] [Related]
2. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
Rényi L
Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of 5-methoxy-N,N-dimethyltryptamine-induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission.
Archer T; Tandberg B; Rènyi L; Ross SB
J Pharm Pharmacol; 1985 Sep; 37(9):648-50. PubMed ID: 2867187
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
Gudelsky GA; Koenig JI; Jackman H; Meltzer HY
Psychopharmacology (Berl); 1986; 90(3):403-7. PubMed ID: 2947256
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine-mediated behaviour in male and female rats.
Dickinson SL; Curzon G
Neuropharmacology; 1986 Jul; 25(7):771-6. PubMed ID: 3748324
[TBL] [Abstract][Full Text] [Related]
6. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
8. Ejaculations induced by p-chloroamphetamine in the rat.
Rènyi L
Neuropharmacology; 1985 Aug; 24(8):697-704. PubMed ID: 3837857
[TBL] [Abstract][Full Text] [Related]
9. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
Ask AL; Fagervall I; Huang RB; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
[TBL] [Abstract][Full Text] [Related]
10. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
11. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
Benmansour S; Brunswick DJ
Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
[TBL] [Abstract][Full Text] [Related]
12. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
[TBL] [Abstract][Full Text] [Related]
13. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
15. The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity.
Reimann W; Schneider F
Gen Pharmacol; 1993 Mar; 24(2):449-53. PubMed ID: 8482527
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
Barbelivien A; Nyman L; Haapalinna A; Sirviö J
Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
[TBL] [Abstract][Full Text] [Related]
17. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
Boden R; Botting R; Coulson P; Spanswick G
Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
Fletcher PJ; Yu PH
Psychopharmacology (Berl); 1989; 98(2):265-8. PubMed ID: 2502797
[TBL] [Abstract][Full Text] [Related]
19. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
